Skip to main content
Top
Published in: Journal of Gastroenterology 9/2007

01-09-2007 | Liver, Pancreas, and Biliary Tract

Fecal calprotectin and elastase 1 determinations in patients with pancreatic diseases: a possible link between pancreatic insufficiency and intestinal inflammation

Authors: Raffaele Pezzilli, Alessandra Barassi, Antonio M. Morselli-Labate, Lorenzo Fantini, Paola Tomassetti, Davide Campana, Riccardo Casadei, Sergio Finazzi, Gianvico Melzi d'Eril, Roberto Corinaldesi

Published in: Journal of Gastroenterology | Issue 9/2007

Login to get access
Metadata
Title
Fecal calprotectin and elastase 1 determinations in patients with pancreatic diseases: a possible link between pancreatic insufficiency and intestinal inflammation
Authors
Raffaele Pezzilli
Alessandra Barassi
Antonio M. Morselli-Labate
Lorenzo Fantini
Paola Tomassetti
Davide Campana
Riccardo Casadei
Sergio Finazzi
Gianvico Melzi d'Eril
Roberto Corinaldesi
Publication date
01-09-2007
Publisher
Springer-Verlag
Published in
Journal of Gastroenterology / Issue 9/2007
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-007-2086-0

Other articles of this Issue 9/2007

Journal of Gastroenterology 9/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine